Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.5300 (-0.07%) ($13.5300 - $13.6150) on Tue. Aug. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.98% (three month average) | RSI | 65 | Latest Price | $13.5300(-0.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(46%) IBB(46%) ARKK(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.49% in a week (0% probabilities). VIXM(-37%) VXX(-28%) UNG(-13%) TLT(-10%) USO(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.49% (StdDev 2.98%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.83(5.46%) | 10 Day Moving Average | $12.68(6.7%) | 20 Day Moving Average | $12.72(6.37%) | To recent high | -18.3% | To recent low | 12.7% | Market Cap | $1.005b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |